JANUMET Side Effects

6837452-3 | Anaemia, Epigastric Discomfort
on Jul 09, 2010 Female patient from PHILIPPINES , 70 years of age, was diagnosed with diabetes mellitus and was treated with Janumet (View Usage). Patient experienced the following unwanted or unexpected effects: anaemia, epigastric discomfort. Janumet dosage: . Patient was hospitalized.

6837448-1 | Balance Disorder, Fall
Patient was taking Janumet (View Usage). Patient had the following side effects: balance disorder, fall (What is fall?) on Jul 08, 2010 from FRANCE Additional patient health information: Female patient , 75 years of age, was diagnosed with type 2 diabetes mellitus and. Janumet dosage: . During the same period patient was treated with PROPOXYPHENE (View Propoxyphene Review and Propoxyphene Label ). Patient was hospitalized.

6827062-6 | Aphasia, Coma, Hypoglycaemia
Adverse event was reported on Jul 05, 2010 by a Male patient taking Janumet (View Usage) (Dosage: ) was diagnosed with type 2 diabetes mellitus and. Location: FRANCE , 71 years of age, After Janumet was administered, patient had the following side effects: aphasia (What is aphasia?), coma, hypoglycaemia. During the same period patient was treated with GLICLAZIDE (View Gliclazide Review and Gliclazide Label ), METFORMIN (View Metformin Review and Metformin Label ), CEFTRIAXONE SODIUM (View Ceftriaxone Sodium Review and Ceftriaxone Sodium Label ), POTASSIUM CHLORIDE (View Potassium Chloride Review and Potassium Chloride Label ), LISINOPRIL (View Lisinopril Review and Lisinopril Label ), FUROSEMIDE (View Furosemide Review and Furosemide Label ), AMIODARONE HYDROCHLORIDE (View Amiodarone Hydrochloride Review and Amiodarone Hydrochloride Label ), CARVEDILOL (View Carvedilol Review and Carvedilol Label ). Patient was hospitalized.

6824529-1 | Renal Failure, Tubulointerstitial Nephritis
on Jul 02, 2010 Female patient from GERMANY , 68 years of age, weighting 127.9 lb, was diagnosed with diabetes mellitus and was treated with Janumet (View Usage). Patient experienced the following unwanted or unexpected effects: renal failure, tubulointerstitial nephritis. Janumet dosage: . Patient was hospitalized and became disabled.


6823091-7 | Chest Pain, Gastrointestinal Pain, Hepatitis
on Jul 06, 2010 Female patient from GERMANY , 61 years of age, weighting 136.7 lb, was diagnosed with type 2 diabetes mellitus and was treated with Janumet (View Usage). Patient had the following side effects: chest pain (What is chest pain?), gastrointestinal pain, hepatitis (What is hepatitis?). Janumet dosage: . Patient was hospitalized.

6823082-6 | Abdominal Pain, Back Disorder, Bowel Movement Irregularity, Cholelithiasis, Constipation, Lipase Increased, Nephrolithiasis, Pancreatitis Relapsing
Patient was taking Janumet (View Usage). After Janumet was administered, patient had the following side effects: abdominal pain (What is abdominal pain?), back disorder, bowel movement irregularity, cholelithiasis, constipation (What is constipation?), lipase increased, nephrolithiasis, pancreatitis relapsing on Jun 29, 2010 from UNITED STATES Additional patient health information: Male patient , 56 years of age, was diagnosed with diabetes mellitus and. Janumet dosage: . During the same period patient was treated with GLIPIZIDE (View Glipizide Review and Glipizide Label ), LISINOPRIL (View Lisinopril Review and Lisinopril Label ), CRESTOR (View Crestor Review and Crestor Label ), NIACIN (View Niacin Review and Niacin Label ). Patient was hospitalized.

6820159-6 | Fall, Malaise, Thrombocytopenia
Adverse event was reported on Jul 01, 2010 by a Female patient taking Janumet (View Usage) (Dosage: ) was diagnosed with type 2 diabetes mellitus, hypertension and. Location: FRANCE , 85 years of age, Patient experienced the following unwanted or unexpected effects: fall (What is fall?), malaise, thrombocytopenia. During the same period patient was treated with ALPRAZOLAM (View Alprazolam Review and Alprazolam Label ), OLMESARTAN MEDOXOMIL (View Olmesartan Medoxomil Review and Olmesartan Medoxomil Label ). Patient was hospitalized.

6815034-7 | Abdominal Discomfort, Abdominal Pain Upper, Arthralgia, Asthenia, Dehydration, Dizziness, Fatigue, Headache
on Jun 30, 2010 Male patient from UNITED STATES , weighting 172.0 lb, was diagnosed with diabetes mellitus and was treated with Janumet (View Usage). Patient had the following side effects: abdominal discomfort, abdominal pain upper, arthralgia, asthenia, dehydration, dizziness (What is dizziness?), fatigue, headache (What is headache?). Janumet dosage: One Once A Day Po Appx. Three Weeks.

6813744-9 | Renal Failure Acute, Sensation Of Foreign Body, Tubulointerstitial Nephritis
on Jun 25, 2010 Male patient from GERMANY , 64 years of age, weighting 205.0 lb, was diagnosed with diabetes mellitus, hypercholesterolaemia, hypertension and was treated with Janumet (View Usage). After Janumet was administered, patient had the following side effects: renal failure acute, sensation of foreign body, tubulointerstitial nephritis. Janumet dosage: . During the same period patient was treated with INSULIN GLARGINE (View Insulin Glargine Review and Insulin Glargine Label ), SIMVASTATIN (View Simvastatin Review and Simvastatin Label ), BISOPROLOL (View Bisoprolol Review and Bisoprolol Label ), ENALAPRIL MALEATE AND HYDROCHLOROTHIAZIDE (View Enalapril Maleate And Hydrochlorothiazide Review and Enalapril Maleate And Hydrochlorothiazide Label ). Patient was hospitalized and became disabled.

6811331-X | Renal Failure Acute
Patient was taking Janumet (View Usage). Patient experienced the following unwanted or unexpected effects: renal failure acute on Jun 25, 2010 from GERMANY Additional patient health information: Male patient , 64 years of age, weighting 205.0 lb, was diagnosed with diabetes mellitus, hypercholesterolaemia, hypertension and. Janumet dosage: . During the same period patient was treated with INSULIN GLARGINE (View Insulin Glargine Review and Insulin Glargine Label ), SIMVASTATIN (View Simvastatin Review and Simvastatin Label ), BISOPROLOL (View Bisoprolol Review and Bisoprolol Label ), ENALAPRIL MALEATE AND HYDROCHLOROTHIAZIDE (View Enalapril Maleate And Hydrochlorothiazide Review and Enalapril Maleate And Hydrochlorothiazide Label ). Patient was hospitalized and became disabled.

6811325-4 | Diabetes Mellitus, Hyperglycaemia, Oedema Peripheral
Adverse event was reported on Jun 21, 2010 by a Female patient taking Janumet (View Usage) (Dosage: ) was diagnosed with type 2 diabetes mellitus and. Location: FRANCE , 76 years of age, Patient had the following side effects: diabetes mellitus, hyperglycaemia, oedema peripheral. During the same period patient was treated with INSULIN (View Insulin Review and Insulin Label ). Patient was hospitalized.

6811213-3 | Burns Second Degree, Cellulitis, Renal Failure, Vasculitis
on Jun 29, 2010 Female patient from UNITED STATES , 66 years of age, weighting 320.0 lb, was diagnosed with blood glucose abnormal and was treated with Janumet (View Usage). After Janumet was administered, patient had the following side effects: burns second degree, cellulitis (What is cellulitis?), renal failure, vasculitis (What is vasculitis?). Janumet dosage: Daily Am Pm. Patient was hospitalized.

6810210-1 | Convulsion
on Jun 22, 2010 Male patient from UNITED STATES , 50 years of age, was diagnosed with diabetes mellitus and was treated with Janumet (View Usage). Patient experienced the following unwanted or unexpected effects: convulsion. Janumet dosage: .

6810209-5 | Convulsion
Patient was taking Janumet (View Usage). Patient had the following side effects: convulsion on Jun 22, 2010 from UNITED STATES Additional patient health information: Male patient , 60 years of age, was diagnosed with diabetes mellitus and. Janumet dosage: . Patient was hospitalized.

6792435-7 | Back Disorder, Bowel Movement Irregularity, Cholelithiasis, Lipase Increased, Pain
Adverse event was reported on Jun 17, 2010 by a Male patient taking Janumet (View Usage) (Dosage: ) was diagnosed with diabetes mellitus and. Location: UNITED STATES , 56 years of age, After Janumet was administered, patient had the following side effects: back disorder, bowel movement irregularity, cholelithiasis, lipase increased, pain (What is pain?). During the same period patient was treated with GLIPIZIDE (View Glipizide Review and Glipizide Label ), LISINOPRIL (View Lisinopril Review and Lisinopril Label ), CRESTOR (View Crestor Review and Crestor Label ), NIACIN (View Niacin Review and Niacin Label ). Patient was hospitalized.

6787555-7 | Back Disorder, Bowel Movement Irregularity, Cholelithiasis, Lipase Increased, Pain
on Jun 17, 2010 Male patient from UNITED STATES , 56 years of age, was diagnosed with diabetes mellitus and was treated with Janumet (View Usage). Patient experienced the following unwanted or unexpected effects: back disorder, bowel movement irregularity, cholelithiasis, lipase increased, pain (What is pain?). Janumet dosage: . During the same period patient was treated with GLIPIZIDE (View Glipizide Review and Glipizide Label ), LISINOPRIL (View Lisinopril Review and Lisinopril Label ), CRESTOR (View Crestor Review and Crestor Label ), NIACIN (View Niacin Review and Niacin Label ). Patient was hospitalized.

6782116-8 | Anxiety, Blood Pressure Fluctuation, Dyskinesia, Excessive Eye Blinking, Headache
on Jun 08, 2010 Female patient from UNITED STATES , 73 years of age, weighting 154.3 lb, was diagnosed with diabetes mellitus and was treated with Janumet (View Usage). Patient had the following side effects: anxiety (What is anxiety?), blood pressure fluctuation, dyskinesia, excessive eye blinking, headache (What is headache?). Janumet dosage: . During the same period patient was treated with GLYBURIDE (View Glyburide Review and Glyburide Label ), RAMIPRIL (View Ramipril Review and Ramipril Label ), NEXIUM (View Nexium Review and Nexium Label ), METFORMIN (View Metformin Review and Metformin Label ).

6774731-2 | Product Quality Issue
Patient was taking Janumet (View Usage). After Janumet was administered, patient had the following side effects: product quality issue on Jun 15, 2010 from UNITED STATES Additional patient health information: Male patient , 75 years of age, weighting 260.0 lb, . Janumet dosage: .

6773445-2 | Alanine Aminotransferase Increased, Aspartate Aminotransferase Increased, Gamma-glutamyltransferase Increased, Lipase Increased
Adverse event was reported on Jun 10, 2010 by a Female patient taking Janumet (View Usage) (Dosage: ) was diagnosed with type 2 diabetes mellitus, hypertension and. Location: FRANCE , 59 years of age, weighting 156.5 lb, Patient experienced the following unwanted or unexpected effects: alanine aminotransferase increased, aspartate aminotransferase increased, gamma-glutamyltransferase increased, lipase increased. During the same period patient was treated with VALSARTAN (View Valsartan Review and Valsartan Label ).

6770749-4 | Alanine Aminotransferase Increased, Aspartate Aminotransferase Increased, Gamma-glutamyltransferase Increased, Lipase Increased
on Jun 10, 2010 Female patient from FRANCE , 59 years of age, weighting 156.5 lb, was diagnosed with type 2 diabetes mellitus, hypertension and was treated with Janumet (View Usage). Patient had the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, gamma-glutamyltransferase increased, lipase increased. Janumet dosage: . During the same period patient was treated with SITAGLIPTIN PHOSPHATE (View Sitagliptin Phosphate Review and Sitagliptin Phosphate Label ), METFORMIN PAMOATE (View Metformin Pamoate Review and Metformin Pamoate Label ), VALSARTAN (View Valsartan Review and Valsartan Label ).

6770184-9 | Glomerulosclerosis, Nephrosclerosis, Renal Failure, Tubulointerstitial Nephritis
on May 06, 2010 Male patient from GERMANY , 81 years of age, was diagnosed with type 2 diabetes mellitus, hypertension and was treated with Janumet (View Usage). After Janumet was administered, patient had the following side effects: glomerulosclerosis, nephrosclerosis, renal failure, tubulointerstitial nephritis. Janumet dosage: . During the same period patient was treated with ASPIRIN (View Aspirin Review and Aspirin Label ), BENAZEPRIL HYDROCHLORIDE (View Benazepril Hydrochloride Review and Benazepril Hydrochloride Label ), SIMVASTATIN (View Simvastatin Review and Simvastatin Label ), ZINC OROTATE (View Zinc Orotate Review and Zinc Orotate Label ), ALLOPURINOL (View Allopurinol Review and Allopurinol Label ), SITAGLIPTIN PHOSPHATE (View Sitagliptin Phosphate Review and Sitagliptin Phosphate Label ).

6768797-3 | Azotaemia, Renal Failure Acute, Tubulointerstitial Nephritis
Patient was taking Janumet (View Usage). Patient experienced the following unwanted or unexpected effects: azotaemia, renal failure acute, tubulointerstitial nephritis on Jun 09, 2010 from GERMANY Additional patient health information: Male patient , 64 years of age, weighting 205.0 lb, was diagnosed with diabetes mellitus, hypercholesterolaemia, hypertension and. Janumet dosage: . During the same period patient was treated with INSULIN GLARGINE (View Insulin Glargine Review and Insulin Glargine Label ), SIMVASTATIN (View Simvastatin Review and Simvastatin Label ), BISOPROLOL (View Bisoprolol Review and Bisoprolol Label ), ENALAPRIL MALEATE AND HYDROCHLOROTHIAZIDE (View Enalapril Maleate And Hydrochlorothiazide Review and Enalapril Maleate And Hydrochlorothiazide Label ). Patient was hospitalized and became disabled.

6763203-7 | Atrial Fibrillation, Cerebellar Infarction, Deep Vein Thrombosis, Pelvic Venous Thrombosis, Pulmonary Embolism, Renal Failure Acute, Tracheobronchitis
Adverse event was reported on Jun 02, 2010 by a Male patient taking Janumet (View Usage) (Dosage: ) was diagnosed with diabetes mellitus, hypertension and. Location: GERMANY , 65 years of age, weighting 297.6 lb, Patient had the following side effects: atrial fibrillation (What is atrial fibrillation?), cerebellar infarction, deep vein thrombosis (What is deep vein thrombosis?), pelvic venous thrombosis, pulmonary embolism (What is pulmonary embolism?), renal failure acute, tracheobronchitis. During the same period patient was treated with HYDROCHLOROTHIAZIDE AND TELMISARTAN (View Hydrochlorothiazide And Telmisartan Review and Hydrochlorothiazide And Telmisartan Label ), NEBIVOLOL (View Nebivolol Review and Nebivolol Label ), LERCANIDIPINE HYDROCHLORIDE (View Lercanidipine Hydrochloride Review and Lercanidipine Hydrochloride Label ). Patient was hospitalized.

6762618-0 | Liver Injury
on Jun 04, 2010 Male patient from GERMANY , 54 years of age, weighting 183.0 lb, was diagnosed with type 2 diabetes mellitus, hypertension, hyperuricaemia, hypertriglyceridaemia, hyperlipidaemia and was treated with Janumet (View Usage). After Janumet was administered, patient had the following side effects: liver injury. Janumet dosage: . During the same period patient was treated with ALISKIREN FUMARATE (View Aliskiren Fumarate Review and Aliskiren Fumarate Label ), ALLOPURINOL (View Allopurinol Review and Allopurinol Label ), OMEGA 3 ACID ETHYL ESTERS (View Omega-3 Acid Ethyl Esters Review and Omega-3 Acid Ethyl Esters Label ), RAMIPRIL (View Ramipril Review and Ramipril Label ), ROSUVASTATIN CALCIUM (View Rosuvastatin Calcium Review and Rosuvastatin Calcium Label ), PIOGLITAZONE HCL (View Pioglitazone Hcl Review and Pioglitazone Hcl Label ), METOPROLOL SUCCINATE (View Metoprolol Succinate Review and Metoprolol Succinate Label ), METFORMIN (View Metformin Review and Metformin Label ). Patient was hospitalized.

6762605-2 | Lipase Increased
on Jun 07, 2010 Male patient from FRANCE , 55 years of age, was treated with Janumet (View Usage). Patient experienced the following unwanted or unexpected effects: lipase increased. Janumet dosage: .

6760785-6 | Cardiac Failure, Hypertension, Metabolic Acidosis, Renal Failure Acute
Patient was taking Janumet (View Usage). Patient had the following side effects: cardiac failure, hypertension, metabolic acidosis, renal failure acute on May 31, 2010 from CHILE Additional patient health information: Male patient , 82 years of age, . Janumet dosage: . Patient was hospitalized.

6759448-2 | Pericarditis, Pleural Effusion, Viral Infection
Adverse event was reported on May 27, 2010 by a Male patient taking Janumet (View Usage) (Dosage: ) . Location: ISRAEL , 75 years of age, After Janumet was administered, patient had the following side effects: pericarditis, pleural effusion, viral infection (What is viral infection?). Patient was hospitalized.

6756176-4 | Pancreatitis Acute
on Jun 03, 2010 Male patient from UNITED STATES , 44 years of age, weighting 235.0 lb, was diagnosed with type 2 diabetes mellitus and was treated with Janumet (View Usage). Patient experienced the following unwanted or unexpected effects: pancreatitis acute. Janumet dosage: One Tab Bid Po. Patient was hospitalized.

6754850-7 | Abdominal Pain Upper, Nausea, Pruritus, Rash, Renal Failure, Tubulointerstitial Nephritis, Weight Decreased
on May 28, 2010 Male patient from GERMANY , 64 years of age, weighting 205.0 lb, was diagnosed with diabetes mellitus and was treated with Janumet (View Usage). Patient had the following side effects: abdominal pain upper, nausea (What is nausea?), pruritus, rash (What is rash?), renal failure, tubulointerstitial nephritis, weight decreased. Janumet dosage: . During the same period patient was treated with INSULIN GLARGINE (View Insulin Glargine Review and Insulin Glargine Label ). Patient was hospitalized.

6754847-7 | Atrial Fibrillation, Cerebellar Infarction, Deep Vein Thrombosis, Pelvic Venous Thrombosis, Pulmonary Embolism, Renal Failure Acute, Tracheobronchitis
Patient was taking Janumet (View Usage). After Janumet was administered, patient had the following side effects: atrial fibrillation (What is atrial fibrillation?), cerebellar infarction, deep vein thrombosis (What is deep vein thrombosis?), pelvic venous thrombosis, pulmonary embolism (What is pulmonary embolism?), renal failure acute, tracheobronchitis on Jun 02, 2010 from GERMANY Additional patient health information: Male patient , 65 years of age, weighting 297.6 lb, was diagnosed with diabetes mellitus, hypertension and. Janumet dosage: . During the same period patient was treated with HYDROCHLOROTHIAZIDE AND TELMISARTAN (View Hydrochlorothiazide And Telmisartan Review and Hydrochlorothiazide And Telmisartan Label ), NEBIVOLOL (View Nebivolol Review and Nebivolol Label ), LERCANIDIPINE HYDROCHLORIDE (View Lercanidipine Hydrochloride Review and Lercanidipine Hydrochloride Label ). Patient was hospitalized.

6752014-4 | Cough, Pericarditis, Pleural Effusion, Pyrexia, Rhinorrhoea, Viral Infection
Adverse event was reported on May 27, 2010 by a Male patient taking Janumet (View Usage) (Dosage: ) . Location: ISRAEL , 75 years of age, Patient experienced the following unwanted or unexpected effects: cough, pericarditis, pleural effusion, pyrexia, rhinorrhoea, viral infection (What is viral infection?). Patient was hospitalized.

6745071-2 | Hepatitis
on May 26, 2010 Male patient from GREECE , 76 years of age, was diagnosed with type 2 diabetes mellitus, coronary artery disease (What is coronary artery disease?) and was treated with Janumet (View Usage). Patient had the following side effects: hepatitis (What is hepatitis?). Janumet dosage: . During the same period patient was treated with PRINIVIL (View Prinivil Review and Prinivil Label ), GLUCOPHAGE (View Glucophage Review and Glucophage Label ). Patient was hospitalized.

6736444-2 | Liver Injury
on May 18, 2010 Male patient from GERMANY , 54 years of age, weighting 183.0 lb, was diagnosed with type 2 diabetes mellitus, hypertension, hyperuricaemia, hypertriglyceridaemia, hyperlipidaemia and was treated with Janumet (View Usage). After Janumet was administered, patient had the following side effects: liver injury. Janumet dosage: . During the same period patient was treated with ALISKIREN FUMARATE (View Aliskiren Fumarate Review and Aliskiren Fumarate Label ), ALLOPURINOL (View Allopurinol Review and Allopurinol Label ), OMEGA 3 ACID ETHYL ESTERS (View Omega-3 Acid Ethyl Esters Review and Omega-3 Acid Ethyl Esters Label ), RAMIPRIL (View Ramipril Review and Ramipril Label ), ROSUVASTATIN CALCIUM (View Rosuvastatin Calcium Review and Rosuvastatin Calcium Label ), PIOGLITAZONE HYDROCHLORIDE (View Pioglitazone Hydrochloride Review and Pioglitazone Hydrochloride Label ), METOPROLOL SUCCINATE (View Metoprolol Succinate Review and Metoprolol Succinate Label ), METFORMIN (View Metformin Review and Metformin Label ). Patient was hospitalized.

6736423-5 | Mucosal Haemorrhage, Thrombocytopenia
Patient was taking Janumet (View Usage). Patient experienced the following unwanted or unexpected effects: mucosal haemorrhage, thrombocytopenia on May 12, 2010 from GERMANY Additional patient health information: Female patient , 61 years of age, weighting 198.4 lb, was diagnosed with type 2 diabetes mellitus, hypertension, thrombocytopenia and. Janumet dosage: . During the same period patient was treated with RASILEZ (View Rasilez Review and Rasilez Label ), DECORTIN (View Decortin Review and Decortin Label ), BISOPROLOL (View Bisoprolol Review and Bisoprolol Label ). Patient was hospitalized.

6731311-2 | Pneumonia
Adverse event was reported on May 11, 2010 by a Male patient taking Janumet (View Usage) (Dosage: ) was diagnosed with type 2 diabetes mellitus and. Location: NETHERLANDS , 71 years of age, weighting 242.5 lb, Patient had the following side effects: pneumonia (What is pneumonia?). During the same period patient was treated with ASPIRIN CALCIUM (View Aspirin Calcium Review and Aspirin Calcium Label ), PANTOPRAZOLE (View Pantoprazole Review and Pantoprazole Label ), ZOCOR (View Zocor Review and Zocor Label ), ZESTORETIC (View Zestoretic Review and Zestoretic Label ). Patient was hospitalized.

6724206-1 | Glomerulosclerosis, Nephrosclerosis, Renal Failure, Tubulointerstitial Nephritis
on May 06, 2010 Male patient from GERMANY , 81 years of age, was diagnosed with type 2 diabetes mellitus, hypertension and was treated with Janumet (View Usage). After Janumet was administered, patient had the following side effects: glomerulosclerosis, nephrosclerosis, renal failure, tubulointerstitial nephritis. Janumet dosage: . During the same period patient was treated with ASPIRIN (View Aspirin Review and Aspirin Label ), BENAZEPRIL HYDROCHLORIDE (View Benazepril Hydrochloride Review and Benazepril Hydrochloride Label ), SIMVASTATIN (View Simvastatin Review and Simvastatin Label ), ZINC OROTATE (View Zinc Orotate Review and Zinc Orotate Label ), ALLOPURINOL (View Allopurinol Review and Allopurinol Label ), JANUVIA (View Januvia Review and Januvia Label ).

6722577-3 | Blood Glucose Abnormal, Pancreatitis
on Jan 08, 2010 Male patient from UNITED STATES , 42 years of age, was diagnosed with diabetes mellitus and was treated with Janumet (View Usage). Patient experienced the following unwanted or unexpected effects: blood glucose abnormal, pancreatitis. Janumet dosage: Po. During the same period patient was treated with JANUVIA (View Januvia Review and Januvia Label ). Patient was hospitalized.

6722576-1 | Pancreatitis
Patient was taking Janumet (View Usage). Patient had the following side effects: pancreatitis on Jan 15, 2010 from UNITED STATES Additional patient health information: Male patient , 75 years of age, was diagnosed with diabetes mellitus and. Janumet dosage: Po. During the same period patient was treated with DIOVAN (View Diovan Review and Diovan Label ), ASPIRIN (View Aspirin Review and Aspirin Label ). Patient was hospitalized.

6722559-1 | Pancreatitis
Adverse event was reported on Feb 02, 2010 by a Female patient taking Janumet (View Usage) (Dosage: Po) was diagnosed with type 2 diabetes mellitus and. Location: UNITED STATES , 50 years of age, After Janumet was administered, patient had the following side effects: pancreatitis.

6722557-8 | Pancreatitis Acute
on Feb 22, 2010 Male patient from UNITED STATES , 54 years of age, was diagnosed with diabetes mellitus and was treated with Janumet (View Usage). Patient experienced the following unwanted or unexpected effects: pancreatitis acute. Janumet dosage: Po. During the same period patient was treated with INSULIN (View Insulin Review and Insulin Label ). Patient was hospitalized and became disabled.

6722549-9 | Pancreatitis
on Feb 24, 2010 Female patient from UNITED STATES , 52 years of age, was diagnosed with blood glucose and was treated with Janumet (View Usage). Patient had the following side effects: pancreatitis. Janumet dosage: 500mg/50mg/bid/po. During the same period patient was treated with INSULIN (View Insulin Review and Insulin Label ), METOPROLOL TARTRATE (View Metoprolol Tartrate Review and Metoprolol Tartrate Label ), SIMVASTATIN (View Simvastatin Review and Simvastatin Label ).

6722547-5 | Pancreatitis
Patient was taking Janumet (View Usage). After Janumet was administered, patient had the following side effects: pancreatitis on Mar 15, 2010 from UNITED STATES Additional patient health information: Male patient , 52 years of age, was diagnosed with type 2 diabetes mellitus and. Janumet dosage: Po. During the same period patient was treated with ENALAPRIL MALEATE (View Enalapril Maleate Review and Enalapril Maleate Label ). Patient was hospitalized.

6722183-0 | Upper Gastrointestinal Haemorrhage
Adverse event was reported on May 06, 2010 by a Male patient taking Janumet (View Usage) (Dosage: ) was diagnosed with diabetes mellitus, gout (What is gout?), hypertension, hyperlipidaemia and. Location: SPAIN , 60 years of age, weighting 183.0 lb, Patient experienced the following unwanted or unexpected effects: upper gastrointestinal haemorrhage. During the same period patient was treated with ALLOPURINOL (View Allopurinol Review and Allopurinol Label ), AMLODIPINE (View Amlodipine Review and Amlodipine Label ), HYDROCHLOROTHIAZIDE AND VALSARTAN (View Hydrochlorothiazide And Valsartan Review and Hydrochlorothiazide And Valsartan Label ), SIMVASTATIN (View Simvastatin Review and Simvastatin Label ), GLICLAZIDE (View Gliclazide Review and Gliclazide Label ).

6722181-7 | Weight Increased
on May 10, 2010 Male patient from UNITED STATES , 63 years of age, weighting 264.6 lb, was diagnosed with diabetes mellitus and was treated with Janumet (View Usage). Patient had the following side effects: weight increased. Janumet dosage: . During the same period patient was treated with AMARYL (View Amaryl Review and Amaryl Label ), DIOVAN (View Diovan Review and Diovan Label ), ALAVERT (View Alavert Review and Alavert Label ).

6720503-4 | Pruritus, Rash Maculo-papular, Tongue Oedema
on May 03, 2010 Male patient from PORTUGAL , 61 years of age, weighting 158.7 lb, was diagnosed with type 2 diabetes mellitus, hypertension, dyslipidaemia, multiple allergies, cardiovascular disorder and was treated with Janumet (View Usage). After Janumet was administered, patient had the following side effects: pruritus, rash maculo-papular, tongue oedema. Janumet dosage: . During the same period patient was treated with OLMESARTAN MEDOXOMIL (View Olmesartan Medoxomil Review and Olmesartan Medoxomil Label ), HYDROCHLOROTHIAZIDE (View Hydrochlorothiazide Review and Hydrochlorothiazide Label ), METFORMIN HYDROCHLORIDE (View Metformin Hydrochloride Review and Metformin Hydrochloride Label ), SIMVASTATIN (View Simvastatin Review and Simvastatin Label ), CETIRIZINE HYDROCHLORIDE (View Cetirizine Hydrochloride Review and Cetirizine Hydrochloride Label ), ASPIRIN (View Aspirin Review and Aspirin Label ).

6718612-9 | Cardiac Failure
Patient was taking Janumet (View Usage). Patient experienced the following unwanted or unexpected effects: cardiac failure on May 05, 2010 from FRANCE Additional patient health information: Male patient , 70 years of age, was diagnosed with type 2 diabetes mellitus and. Janumet dosage: . During the same period patient was treated with DIAMICRON (View Diamicron Review and Diamicron Label ), METFORMIN (View Metformin Review and Metformin Label ).

6717861-3 | Abdominal Pain Upper, Alanine Aminotransferase Increased, Flatulence, Hepatic Enzyme Increased, Pancreatic Enzymes Increased
Adverse event was reported on May 04, 2010 by a Male patient taking Janumet (View Usage) (Dosage: ) was diagnosed with diabetes mellitus inadequate control and. Location: GERMANY , 49 years of age, weighting 198.4 lb, Patient had the following side effects: abdominal pain upper, alanine aminotransferase increased, flatulence, hepatic enzyme increased, pancreatic enzymes increased. During the same period patient was treated with JANUVIA (View Januvia Review and Januvia Label ), METFORMIN (View Metformin Review and Metformin Label ).

6717850-9 | Adverse Event, Blood Cholesterol Increased, Gamma-glutamyltransferase Increased
on May 06, 2010 Female patient from GERMANY , 53 years of age, was diagnosed with type 2 diabetes mellitus and was treated with Janumet (View Usage). After Janumet was administered, patient had the following side effects: adverse event, blood cholesterol increased, gamma-glutamyltransferase increased. Janumet dosage: .

6714454-9 | Pruritus, Rash Maculo-papular, Tongue Oedema
on May 03, 2010 Male patient from PORTUGAL , 61 years of age, weighting 158.7 lb, was diagnosed with type 2 diabetes mellitus, hypertension, dyslipidaemia, multiple allergies, cardiovascular disorder and was treated with Janumet (View Usage). Patient experienced the following unwanted or unexpected effects: pruritus, rash maculo-papular, tongue oedema. Janumet dosage: . During the same period patient was treated with OLMESARTAN MEDOXOMIL (View Olmesartan Medoxomil Review and Olmesartan Medoxomil Label ), HYDROCHLOROTHIAZIDE (View Hydrochlorothiazide Review and Hydrochlorothiazide Label ), METFORMIN HYDROCHLORIDE (View Metformin Hydrochloride Review and Metformin Hydrochloride Label ), SIMVASTATIN (View Simvastatin Review and Simvastatin Label ), CETIRIZINE HYDROCHLORIDE (View Cetirizine Hydrochloride Review and Cetirizine Hydrochloride Label ), ASPIRIN (View Aspirin Review and Aspirin Label ).

6711886-X | Fall, Malaise, Thrombocytopenia
Patient was taking Janumet (View Usage). Patient had the following side effects: fall (What is fall?), malaise, thrombocytopenia on Apr 29, 2010 from FRANCE Additional patient health information: Female patient , 85 years of age, was diagnosed with type 2 diabetes mellitus, hypertension and. Janumet dosage: . During the same period patient was treated with JANUVIA (View Januvia Review and Januvia Label ), METFORMIN (View Metformin Review and Metformin Label ), ALPRAZOLAM (View Alprazolam Review and Alprazolam Label ), OLMESARTAN MEDOXOMIL (View Olmesartan Medoxomil Review and Olmesartan Medoxomil Label ). Patient was hospitalized.